Eileen Brantley, PhD Assistant Professor, Basic Sciences School of Medicine Assistant Professor, Pharmaceutical Sciences School of Pharmacy

Presentations 

  Research Presentations -- Local/Campus

• A seminar presentation entitled "An Account of the Preclinical Evaluation of Phortress as an Anticancer Agent" was given on October 11, 2007 at Loma Linda University. ( 10/2007 )

  Poster Presentation

• E. Brantley, C. Watkins, L. McLean, L. Amis and W. Davis. 5F 203 modulates oxidative stress, induces single strand breaks and promote mitochondrial membrane potential loss in breast cancer cells. Poster presentation at the American Association for Cancer Research (AACR) meeting in Washington, DC. ( 4/2010 )

• Davis W., Garispe E., Whitley R., Marks B., Stelling C., Zylstra D., Lucinian T., and Brantley E. Low Concentrations of Hydrogen Peroxide Induce Altered Physiology of Human Diploid Fibroblasts. Presented at the Annual FASEB meeting in New Orleans, LA. ( 4/2009 )

• Zylstra D., Marks B., Whitley R., Stelling C., Amis L., Brantley E. and Davis W. Antioxidants perturb the effectiveness of aminoflavone and benzothiazole treatment in breast cancer cell lines derived from African-American women.  Presented at the Science of Cancer Health Disparities American Association for Cancer Research meeting, (Carefree, AZ) ( 2/2009 )

• Vickers H., Bravo B., Butler D., Figueroa J., Davis W., and Brantley E. The expression of activating transcription factor 3 (ATF-3) in 5F 203-mediated breast cancer cells.  Presented at the Loma Linda University summer research symposium sponsored by the Center or Health Disparities and Molecular Medicine. ( 8/2008 )

• McLean L., Davis, W.L., Jr., Sowers L. and Brantley E. 5F 203-induced apoptosis involves oxidative stress and caspase activation in sensitive breast cancer cells. Presented at the 99th Annual American Association for Cancer Research meeting, San Diego, CA. ( 4/2008 )

• Brantley, E., Amis L. and Davis, W.L., Jr. Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients.  Presented at the Science of Cancer Health Disparities American Association for Cancer Research meeting, Atlanta, GA. ( 11/2007 )

• Jimenez R., Amis L., Davis W., and Brantley E. Aminoflavone-induced anticancer activity is attenuated in MDA-MB-468 human breast cancer cells pretreated with the DNA methyltransferase inhibitor 5aza-2''''deoxycitidine. Presented at Loma Linda University research symposium sponsored by the Center for Health Disparities and Molecular Medicine ( 8/2007 )

• Jimenez R. and Brantley E. Aminoflavone modulates reactive oxygen species formation in a cytochrome P450 1A-dependent manner in estrogen receptor negative MDA-MB-468 breast cancer cells. Presented at the Loma Linda University research symposium sponsored by the Center for Health Disparities and Molecular Medicine ( 7/2006 )

  Presentations given to non-academic audiences

• Lancelot McLean, Carlos Casiano, Ubaldo Soto, Lawrence Sowers and Eileen Brantley. Growth inhibitory effects of Aminoflavone in estrogen receptor negative MDA-MB-468 breast cancer cells . Presented at the 2006 Annual American Association for Cancer Research meeting. Washington, D.C. ( 4/2006 )